<p>Dr. Hilal, of the Mayo Clinic, joins Chadi Nabhan, MD, MBA, FACP, on “The HemOnc Pulse” to discuss measurable residual disease (MRD) and the debates surrounding its use for response assessment in patients with chronic lymphocytic leukemia (CLL).</p>

Dr. Hilal, of the Mayo Clinic, joins Chadi Nabhan, MD, MBA, FACP, on “The HemOnc Pulse” to discuss measurable residual disease (MRD) and the debates surrounding its use for response assessment in patients with chronic lymphocytic leukemia (CLL).

Discussing the Role of MRD in CLL With Talal Hilal, MD

Blood Cancers Today and the Society of Hematologic Oncology bring you The HemOnc Pulse, a podcast hosted by Rahul Banerjee, MD, covering all topics in the world of hematologic oncology.

Share Discussing the Role of MRD in CLL With Talal Hilal, MD

Sign up to save your podcasts

Discussing the Role of MRD in CLL With Talal Hilal, MD

Discussing the Role of MRD in CLL With Talal Hilal, MD

More shows like The HemOnc Pulse

JAMA Editors' Summary

Pod Save America

The Daily

The Ezra Klein Show

WolverHeme Happy Hour